ACM Research, Inc. (ACMR) Is a Trending Stock: Facts to Know Before Betting on It

ACM Research (ACMR) is trending, but faces headwinds according to Zacks, with a Rank #4 (Sell) indicating potential near-term underperformance. While the company's last quarter saw revenue of $172.35 million (+13.3% Y/Y) and EPS of $0.46, beating estimates, consensus earnings estimates have been revised downward for the current quarter (-23.6% Y/Y to $0.42) and fiscal year (-11.5% Y/Y to $2.00), despite projected revenue growth of +17.2% for the current fiscal year.

Analysis

ACM Research (ACMR) has garnered significant investor attention, yet its stock's +5.6% return over the past month trails both the S&P 500 composite's +8.2% and its Zacks Semiconductor Equipment - Material Services industry's +15.6% gains. Despite a consistent history of exceeding earnings and revenue consensus—highlighted by a +6.06% revenue surprise ($172.35 million, +13.3% Y/Y) and a +24.32% EPS surprise ($0.46) in its last reported quarter—the near-term outlook is tempered by downward revisions to earnings estimates. Current quarter EPS is anticipated at $0.42, a -23.6% year-over-year decrease, with consensus estimates falling by -13.3% in the last 30 days. Similarly, the current fiscal year's EPS forecast of $2.00 indicates an -11.5% decline from the prior year, following a -2.2% downward revision. While the subsequent fiscal year projects a +10% EPS rebound to $2.20, this estimate has also been cut by -12% over the past month. This contrasts with sustained projected revenue growth: current quarter sales are expected at $223.16 million (+10.2% Y/Y), with full-year estimates pointing to +17.2% and +16.7% growth for the current and next fiscal years, respectively. The company's Zacks Value Style Score of C suggests it trades at par with peers, but the overriding concern from negative earnings revisions contributes to its Zacks Rank #4 (Sell), indicating potential for near-term market underperformance.

Key Decisions for Investors

• Investors should approach ACM Research with caution, primarily due to its Zacks Rank #4 (Sell) and the significant recent downward revisions in consensus earnings estimates for the current quarter (EPS $0.42, -23.6% Y/Y, estimate down -13.3% in 30 days) and the next fiscal year (estimate down -12% in 30 days), despite its history of surpassing quarterly expectations.
• The divergence between robust projected revenue growth, with current fiscal year sales expected to increase by +17.2% to $916.67 million, and declining earnings expectations, such as the -11.5% Y/Y drop in EPS to $2.00 for the current fiscal year, warrants close monitoring in upcoming financial disclosures.
• Considering ACMR's recent stock return of +5.6% underperforming its industry (+15.6%), coupled with the cautious forward-looking earnings sentiment, investors might await signs of stabilization or positive shifts in earnings estimate revisions before considering new or increased positions.